Search Thermo Fisher Scientific
Specificity: This antibody binds native and reduced human VEGF (isoform 165).
Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Avastin